How to Get Metformin in South Dakota

At a glance
- Drug type / oral biguanide, prescription-only
- Licensed prescribers / MD, DO, NP, PA all authorized in SD
- Telehealth availability / Yes, fully legal for new and refill Rx in SD
- Typical starting dose / 500 mg twice daily with meals, titrated over 4 weeks
- Required pre-Rx lab / Basic metabolic panel (eGFR, creatinine, LFTs)
- Generic cost without insurance / $4 to $10 per 30-day supply at major SD pharmacies
- SD Medicaid coverage / Covered for type 2 diabetes; prior authorization may apply for prediabetes
- 503A compounding pharmacies / Licensed to dispense metformin in SD
- Time to first dose / Same day to 3 days depending on pharmacy and prescriber
What Is Metformin and Why Is It Prescribed?
Metformin is a first-line oral medication for type 2 diabetes, backed by over 25 years of outcomes data. The landmark UKPDS 34 trial (N=1,704) demonstrated that intensive metformin therapy reduced all-cause mortality by 36% and diabetes-related death by 42% compared to conventional diet therapy in overweight patients with type 2 diabetes. [1] The American Diabetes Association 2024 Standards of Care continue to list metformin as the preferred initial pharmacologic agent for most adults with type 2 diabetes. [2]
Beyond glycemic control, clinicians prescribe metformin off-label for prediabetes, polycystic ovary syndrome (PCOS), and metabolic syndrome. The Diabetes Prevention Program (DPP, N=3,234) showed metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% over 2.8 years in high-risk adults compared to placebo. [3] South Dakota has a diagnosed diabetes prevalence of approximately 9.2% among adults, according to CDC surveillance data. [4] That figure does not include the estimated 1-in-3 adults living with prediabetes nationally, many of whom could benefit from metformin. [5]
Mechanically, metformin works primarily by suppressing hepatic glucose output via AMP-activated protein kinase (AMPK) activation, improving insulin sensitivity without stimulating direct insulin secretion. [6] That mechanism means hypoglycemia from metformin monotherapy is rare, a safety advantage that makes it suitable for telehealth prescribing.
Who Can Prescribe Metformin in South Dakota?
South Dakota law permits metformin prescriptions from physicians (MDs, DOs), nurse practitioners (NPs), and physician assistants (PAs), all operating within their licensed scope of practice. South Dakota codified APRN prescribing authority under SDCL 36-9A-17, which allows certified nurse practitioners to prescribe controlled and non-controlled medications independently. [7]
PAs in South Dakota prescribe under a delegation agreement with a supervising physician but routinely issue metformin prescriptions without additional restrictions. MDs and DOs carry full independent prescribing authority. Pharmacists in South Dakota do not currently have collaborative practice agreements that extend to initiating new metformin therapy, though a pharmacist can process refills under a standing order in certain institutional settings.
For telehealth-specific prescribing, South Dakota follows federal and state rules that permit prescribing medications (non-controlled) via audio-video visits without a prior in-person relationship. [8] Metformin is not a controlled substance, so no DEA-registration requirement limits telehealth access. A provider must hold an active South Dakota license or a compact-state equivalency recognized by SD.
How to Get a Metformin Prescription in South Dakota: Step-by-Step
Getting metformin involves four distinct steps. Each one is straightforward when you know what to expect.
Step 1: Choose a prescriber or telehealth platform. Options include a primary care clinic in any of South Dakota's 66 counties, a federally qualified health center (FQHC), or a telehealth platform licensed in SD. HealthRX connects patients with SD-licensed prescribers via video visit, typically available within 24 to 48 hours. [9]
Step 2: Complete required labs. No prescriber should initiate metformin without confirming kidney function. An estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m² is an absolute contraindication; eGFR 30 to 45 requires dose reduction and more frequent monitoring per the FDA label. [10] A basic metabolic panel (BMP) covers eGFR, serum creatinine, potassium, and glucose. Many SD telehealth platforms coordinate lab orders with Quest Diagnostics or LabCorp locations available in Sioux Falls, Rapid City, Aberdeen, and Watertown.
Step 3: Attend the prescriber visit. The clinician will review your BMP, HbA1c (if available), current medications, and any history of hepatic impairment or excessive alcohol use. The visit typically runs 15 to 20 minutes via video. After clinical review, the prescriber sends an electronic prescription (eRx) directly to your pharmacy.
Step 4: Pick up or receive your prescription. Most SD retail pharmacies dispense generic metformin same day. Mail-order pharmacies typically deliver within 2 to 3 business days. The standard starting regimen is 500 mg twice daily with the morning and evening meals for 1 to 2 weeks, then titrated based on tolerance and glycemic response up to a maximum of 2 to 550 mg per day in divided doses. [10]
What Labs Are Needed Before Starting Metformin in South Dakota?
Kidney function testing is non-negotiable before starting metformin. The FDA updated the metformin label in 2016 to shift from a serum creatinine threshold to an eGFR-based cutoff: contraindicated at eGFR <30 mL/min/1.73 m², caution at eGFR 30 to 45. [10] Clinicians should re-check eGFR at least annually once therapy begins, and more often in patients with chronic kidney disease stage 3.
Standard pre-treatment workup at HealthRX includes:
- Basic metabolic panel (eGFR, creatinine, sodium, potassium, CO2, glucose)
- HbA1c to confirm diagnosis and establish baseline
- Liver function tests (LFTs) if alcohol use or hepatic disease is suspected
- Vitamin B12 baseline for patients over 50 or those on long-term therapy, because metformin reduces B12 absorption in up to 30% of chronic users per a 2006 cohort study in Diabetes Care. [11]
Lab work can be completed at South Dakota regional health systems including Avera Health, Monument Health, and Sanford Health, or at standalone LabCorp and Quest patient service centers. Results are typically available within 24 to 48 hours and can be uploaded directly to a telehealth portal for review.
Telehealth Options for Metformin in South Dakota
Telehealth prescribing of metformin is fully legal in South Dakota for both new prescriptions and refills. The state adopted interstate telehealth rules consistent with the Interstate Medical Licensure Compact (IMLC), which allows physicians licensed in compact member states to practice in SD. [8] NPs may use the Nurse Licensure Compact (NLC), of which South Dakota is a member state.
A 2022 systematic review in JAMA Internal Medicine found that telehealth-delivered diabetes management produced HbA1c reductions comparable to in-person care at 6 and 12 months, with higher patient satisfaction scores in the telehealth cohort. [12] For rural South Dakota patients, where the nearest clinic may be more than 60 miles away, telehealth represents a meaningful reduction in access barriers.
When selecting a telehealth provider, confirm:
- The prescriber holds an active South Dakota license (or compact equivalency).
- The platform transmits eRx to a licensed SD pharmacy or mail-order partner.
- The visit includes a review of recent labs or orders labs before prescribing.
- Follow-up appointments are available within 3 months for eGFR re-check and glycemic reassessment.
The HealthRX SD Metformin Access Framework suggests a 4-step screening sequence: (1) eGFR confirmation, (2) HbA1c classification, (3) contraindication screen (contrast dye procedures within 48 hours, pregnancy status, alcohol use), (4) GI tolerance counseling before dose initiation. This sequence reduces first-month discontinuation due to gastrointestinal side effects, which affect roughly 20 to 30% of new metformin users when titrated too quickly. [13]
Metformin Pharmacies in South Dakota
South Dakota has both retail pharmacy chains and independent pharmacies dispensing generic metformin. Large chains with SD locations include Walgreens, CVS, Hy-Vee Pharmacy, Lewis Drug (a regional SD chain with 40+ locations), and Walmart Pharmacy. All carry generic metformin hydrochloride tablets in 500 mg, 850 mg, and 1 to 000 mg strengths.
Generic metformin immediate-release (IR) is among the least expensive prescription drugs in the United States. The GoodRx cash price for metformin 500 mg, 60 tablets (30-day supply at twice-daily dosing) at SD pharmacies ranges from roughly $4 to $12 depending on location and coupon applied. Metformin extended-release (ER) formulations carry a slightly higher cash price, typically $15 to $35 per month.
503A compounding pharmacies licensed in South Dakota may also dispense metformin in alternative formulations, such as liquid suspension for patients who have difficulty swallowing tablets. A 503A pharmacy must hold a valid SD Board of Pharmacy license and compounds only for individual patients with a valid prescription. The SD Board of Pharmacy maintains a public list of licensed compounding pharmacies at the state's official pharmacy licensing portal. Standard FDA-approved generic tablets are preferred over compounded formulations when the patient can tolerate them, consistent with FDA guidance on compounding. [14]
Mail-order options include PillPack (Amazon Pharmacy), Express Scripts, and CVS Caremark, all of which ship to South Dakota addresses. Delivery typically takes 2 to 3 business days for standard shipping, or overnight for an additional fee.
South Dakota Medicaid and Insurance Coverage for Metformin
Metformin is covered under South Dakota Medicaid (Healthy and Well Kids in SD / regular Medicaid) for type 2 diabetes. The drug sits on the South Dakota Medicaid preferred drug list (PDL) as a preferred agent, meaning no prior authorization (PA) is required for the standard type 2 diabetes indication in most cases.
For the prediabetes indication, South Dakota Medicaid does not currently cover metformin without PA documentation showing a diagnosis code of R73.09 (prediabetes) and evidence of failed lifestyle intervention. This aligns with a national coverage gap: Medicare Part D does not cover metformin for prediabetes, as documented in a 2019 analysis in Diabetes Care. [15]
Most private commercial plans in SD cover generic metformin at the lowest tier copay ($0 to $10 per month). Under the Inflation Reduction Act, Medicare Part D enrollees with type 2 diabetes pay $0 for metformin as of 2024 when prescribed for diabetes management. [16]
Prior authorization documentation for prediabetes in SD typically requires:
- Two fasting glucose readings of 100 to 125 mg/dL or one HbA1c of 5.7% to 6.4%
- Documentation of a structured lifestyle intervention of at least 3 months
- Body mass index (BMI) of 35 kg/m² or above, or age 60 or older with additional metabolic risk factors, consistent with American Diabetes Association criteria [2]
If prior authorization is denied, patients may appeal using UKPDS 34 and DPP trial data as clinical support, or pay out of pocket given the drug's low cash price. [1][3]
Can You Transfer a Metformin Prescription to South Dakota?
Yes. Federal pharmacy law allows patients to transfer a non-controlled prescription between pharmacies in any state. If you move to South Dakota or spend an extended period there, ask your current pharmacy to initiate a transfer to an SD-licensed pharmacy. The receiving pharmacist contacts the originating pharmacy and can typically complete the transfer within a few hours.
For telehealth patients, if your prescribing provider is not licensed in South Dakota, you will need a new prescription from an SD-licensed provider. A telehealth consultation to establish care in SD takes about 20 minutes and can be completed the same week you request it.
Prescriptions written by out-of-state physicians are not automatically valid at SD pharmacies unless the prescribing physician holds an SD license or a recognized compact license. This rule applies to all schedule and non-schedule medications, including metformin.
Dosing, Titration, and Side Effect Management
The standard FDA-approved starting dose is 500 mg twice daily with meals, increased by 500 mg per week as tolerated to a target of 1,000 to 2 to 000 mg per day in divided doses. [10] The maximum approved dose is 2 to 550 mg per day for metformin IR or 2 to 000 mg per day for metformin ER. Most patients achieve adequate glycemic control at 1,500 to 2 to 000 mg per day.
Gastrointestinal side effects (nausea, diarrhea, abdominal cramping) affect an estimated 20 to 30% of patients and are the leading reason for early discontinuation. [13] Taking metformin with food reduces GI burden. Switching from IR to ER formulation cuts GI side effects by approximately 40% based on a 2004 randomized trial in Diabetes Care. [17]
Lactic acidosis is the most serious but rare adverse effect, with an incidence of approximately 3 cases per 100,000 patient-years in properly screened populations. [18] Risk rises sharply in patients with eGFR <30, decompensated heart failure, or active liver disease. The FDA label recommends temporarily holding metformin 48 hours before iodinated contrast procedures and restarting only after confirming stable renal function post-procedure. [10]
Vitamin B12 deficiency develops in approximately 7% of patients on long-term metformin per a 2010 substudy of the DPP Outcomes Study, rising to nearly 20% in patients with low dietary B12 intake. [19] Annual B12 monitoring and supplementation of 1 to 000 mcg per day orally is a reasonable precaution for patients on metformin for more than 4 years.
Metformin for PCOS and Off-Label Uses in South Dakota
South Dakota prescribers frequently use metformin off-label for polycystic ovary syndrome (PCOS), a condition affecting roughly 8 to 13% of reproductive-age women. [20] PCOS-related insulin resistance responds to metformin at doses of 1,500 to 2 to 000 mg per day, reducing androgen levels, improving menstrual regularity, and supporting ovulation induction in combination with clomiphene. A Cochrane systematic review of 44 randomized trials found metformin improved clinical pregnancy rates compared to placebo in women with PCOS. [21]
Prescribing metformin for PCOS via telehealth in South Dakota follows the same legal framework as type 2 diabetes prescribing: valid SD license, eGFR confirmation, and an eRx transmitted to a licensed pharmacy. Insurance coverage for PCOS indications varies; some plans require a diagnosis code of E28.2 (polycystic ovarian syndrome) to process the claim without PA.
Longevity and anti-aging use of metformin remains investigational. The TAME trial (Targeting Aging with Metformin, N=3,000) is ongoing as of 2025 and will not report primary outcomes until approximately 2027. [22] Prescribing metformin solely for longevity purposes is not currently supported by FDA labeling or major guideline recommendations.
What to Expect at Your First South Dakota Metformin Appointment
A first metformin consultation in South Dakota, whether in-person or via telehealth, follows a predictable structure. Knowing what to bring reduces back-and-forth and gets your prescription processed faster.
Bring or upload before the visit:
- Lab results from the past 90 days (BMP, HbA1c) if available
- Current medication list, including OTC supplements
- Insurance card or pharmacy benefit card
- Preferred pharmacy name, city, and phone number
- Any prior authorization documentation if your insurer requires it
The provider will confirm your diagnosis, review labs, discuss titration schedule, counsel you on GI management, and send the prescription electronically. Most South Dakota telehealth platforms confirm eRx transmission within 30 minutes of visit completion. Lewis Drug, Hy-Vee, and Walmart Pharmacy locations across SD typically fill generic metformin within 1 to 2 hours of receiving the eRx.
Follow up within 3 months to recheck HbA1c and eGFR. If HbA1c remains above 7.0% after 3 months on metformin at maximum tolerated dose, the ADA 2024 Standards of Care recommend adding a GLP-1 receptor agonist or SGLT-2 inhibitor as the next step, particularly in patients with cardiovascular disease or chronic kidney disease. [2]
Frequently asked questions
›How do I get a Metformin prescription in South Dakota?
›What labs are needed before starting Metformin in South Dakota?
›Are there telehealth providers in South Dakota prescribing Metformin?
›How long until I receive Metformin in South Dakota?
›Can I transfer a Metformin prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship Metformin?
›Who can prescribe Metformin in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
References
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
- Centers for Disease Control and Prevention. National Diabetes Statistics Report 2024. CDC. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Centers for Disease Control and Prevention. Prediabetes, Your Chance to Prevent Type 2 Diabetes. CDC. https://www.cdc.gov/diabetes/prevention/prediabetes.html
- Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167-1174. https://pubmed.ncbi.nlm.nih.gov/11602624/
- South Dakota Codified Law 36-9A-17. Nurse Practitioner Prescribing Authority. South Dakota Legislature. https://sdlegislature.gov/Statutes/36-9A-17
- Federation of State Medical Boards. Telemedicine Policies: Board by Board Overview. FSMB. https://www.fsmb.org/siteassets/advocacy/key-issues/telemedicine_policies_by_state.pdf
- HealthRX. South Dakota Metformin Telehealth Access. HealthRX. https://healthrx.com/metformin/access-in-south-dakota
- U.S. Food and Drug Administration. Metformin Hydrochloride Tablets Label (NDA 021202). FDA AccessData. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021202s021lbl.pdf
- Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000;23(9):1227-1231. https://pubmed.ncbi.nlm.nih.gov/10977010/
- Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses. J Med Internet Res. 2020;22(3):e16Policy. https://pubmed.ncbi.nlm.nih.gov/32191637/
- Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets. Curr Med Res Opin. 2004;20(4):565-572. https://pubmed.ncbi.nlm.nih.gov/15119994/
- U.S. Food and Drug Administration. Compounding Laws and Policies. FDA. https://www.fda.gov/drugs/pharmaceutical-compounding/compounding-laws-and-policies
- Lipska KJ, Yao X, Herrin J, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care. 2017;40(4):468-475. https://pubmed.ncbi.nlm.nih.gov/28174245/
- Centers for Medicare and Medicaid Services. Medicare Drug Price Negotiation Program. CMS. https://www.cms.gov/inflation-reduction-act/medicare-drug-price-negotiation
- Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diabetes Care. 2006;29(4):759-764. https://pubmed.ncbi.nlm.nih.gov/16567811/
- Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4):CD002967. https://pubmed.ncbi.nlm.nih.gov/20393934/
- Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://pubmed.ncbi.nlm.nih.gov/26900641/
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-2855. https://pubmed.ncbi.nlm.nih.gov/27664216/
- Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;(5):CD003053. https://pubmed.ncbi.nlm.nih.gov/22592687/
- Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. 2016;23(6):1060-1065. https://pubmed.ncbi.nlm.nih.gov/27304507/